Hsa-miR-125b Suppresses Bladder Cancer Development by Down-Regulating Oncogene SIRT7 and Oncogenic Long Non-Coding RNA MALAT1.

Yonghua Han,Yuchen Liu,Hu Zhang,Tiantian Wang,Ruiying Diao,Zhimao Jiang,Yaoting Gui,Zhiming Cai
DOI: https://doi.org/10.1016/j.febslet.2013.10.023
2013-01-01
FEBS Letters
Abstract:MicroRNAs mainly inhibit coding genes and long non-coding RNA expression. Here, we report that hsa-miR-125b and oncogene SIRT7/oncogenic long non-coding RNA MALAT1 were inversely expressed in bladder cancer. Hsa-miR-125b mimic down-regulated, whereas hsa-miR-125b inhibitor up-regulated the expression of SIRT7 and MALAT1. Binding sites were confirmed between hsa-miR-125b and SIRT7/MALAT1. Up-regulation of hsa-miR-125b or down-regulation of SIRT7 inhibited proliferation, motility and increased apoptosis. The effects of up-regulation of hsa-miR-125b were similar to that of silencing MALAT1 in bladder cancer as we had previously described. These data suggest that hsa-miR-125b suppresses bladder cancer development via inhibiting SIRT7 and MALAT1.
What problem does this paper attempt to address?